

Epilepsy Treatment Device Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Epilepsy Treatment Device market is expected to reach USD 3.3 billion by 2025, growing at a CAGR of 6.1%. The market is driven by increasing prevalence of epilepsy, advancements in technology, and rising demand for minimally invasive treatment options. Key players include Medtronic, Abbott Laboratories, and NeuroPace. Request Sample Report
◍ Bausch Health Companies
◍ Neurelis
◍ Veriton Pharma
◍ Zhengzhou Kangjinrui Health Industry Co., Ltd.
The Epilepsy Treatment Device Market is highly competitive with key players such as Medtronic, NeuroPace, and Cyberonics. These companies offer innovative devices like VNS therapy, RNS system, and TMS therapy to treat epilepsy. They contribute to market growth by investing in research, development, and expanding their product portfolio.
◍ Xi'an Qiaofeng Medical Equipment Co., Ltd.
◍ Wuhan Yiruide Medical Equipment
◍ Cerbomed GmbH
◍ electroCore
◍ Cyberonics
◍ NeuroPace
◍ Medtronic
- Medtronic: $10.92 billion in sales revenue
- Cyberonics: $1.40 billion in sales revenue
- NeuroPace: $60 million in sales revenue
Hospital
Outpatient Surgery Center
Neurology Center
Other
Request Sample Report
Mobile
Fixed
Request Sample Report
$ 5.80 Billion